Xtant Medical Holdings XTNT EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Xtant Medical Holdings’s reported figures.
Based on trailing twelve months.
The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xtant Medical Holdings's EBITDA margin?
- Xtant Medical Holdings (XTNT) reported EBITDA margin of 9.2% in Q1 2026.
- How has Xtant Medical Holdings's EBITDA margin changed year-over-year?
- Xtant Medical Holdings's EBITDA margin increased by 447.1% year-over-year, from -2.7% to 9.2%.
- What is the long-term trend for Xtant Medical Holdings's EBITDA margin?
- Over 5 years (2020 to 2025), Xtant Medical Holdings's EBITDA margin has grown at a 36.4% compound annual growth rate (CAGR), from 2.5% to 11.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.